AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Report: Influenza drug market sales to reach $2.5 billion in 2012.

Vaccine Weekly

| December 03, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that influenza drug market sales will reach $2.5 billion in 2012.

According to a new Pharmacor study entitled "Influenza," MedImmune's FluMist and one other intranasal vaccine will account for 60% of the market in 2012.

"MedImmune's FluMist, the first intranasal vaccine and first live-attenuated vaccine for influenza, has been approved by the FDA [Food and Drug Adminstration] and has entered the market in time for the 2003/2004 influenza season," said Jason LaBonte, PhD, analyst at Decision Resources. "FluMist's launch signals an abrupt upward ...

Related articles from newspapers, magazines, journals, and more
70 Million People Affected; Yet Less Than One Third of The Prevalent Population...
Press release article from: PR Newswire April 28, 2003 700+ words
...PRNewswire/ -- Decision Resources, Inc., one of...58% of major-market sales in 2011. "The...Neumeyer, analyst at Decision Resources. "However, fears...Pharmacor from Decision Resources Pharmacor is a...
Influenza Drug Market Sales To Reach $2.5 Billion In 2012; MedImmune's FluMist,...
Press release article from: PR Newswire November 4, 2003 700+ words
...PRNewswire/ -- Decision Resources, Inc., one of...influenza drug market sales will reach $2...analyst at Decision Resources. "FluMist's...Pharmacor from Decision Resources Pharmacor is a...
Milnacipran, Likely the First Drug Approved Specifically for Fibromyalgia, Will...
Press release article from: PR Newswire October 22, 2003 700+ words
...Mass., Oct. 22 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading...physician experts interviewed by Decision Resources. "Both milnacipran and duloxetine...said Stephen Ames, analyst at Decision Resources. "Sales of duloxetine and milnacipran...
Osteoarthritis Drug Market Sales Topped $3.5 Billion in 2002;...
Press release article from: PR Newswire March 1, 2004 700+ words
...Mass., March 1 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading...said Melissa Garland, analyst at Decision Resources. "By 2012, Bextra will capture...in adults. About Pharmacor from Decision Resources Pharmacor is a unique family of studies...
Alzhemed and Flurizan Will be Primary Drivers in Doubling Market Sales of...
Press release article from: PR Newswire March 28, 2005 700+ words
...Mass., March 28 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading...said Michelle Grady, analyst at Decision Resources. "Eisai/Pfizer's Aricept...the illness. About Pharmacor from Decision Resources Pharmacor is a unique family of studies...
Metabolic Syndrome Drug Market to Increase to Nearly $13 Billion by 2013;...
Press release article from: PR Newswire December 8, 2004 700+ words
...PRNewswire/ -- Decision Resources, Inc., a global...forecasts that major-market sales for metabolic syndrome...analyst at Decision Resources. "Despite these...metabolic syndrome, Decision Resources focused on agents...
Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard...
Press release article from: PR Newswire February 25, 2009 700+ words
...New Report from Decision Resources WALTHAM, Mass...PRNewswire/ -- Decision Resources, one of the world...s Angiomax, the market sales leading agent...Angiomax, which was Decision Resources' proprietary clinical...
Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast...
Press release article from: PR Newswire August 6, 2009 700+ words
...PRNewswire/ -- Decision Resources, one of the world...biologics. However, Decision Resources conservatively forecasts...will garner major-market sales of $330 million...690550," said Decision Resources Analyst Joanna Kim...
For more facts and information, see all results

Source: HighBeam Research, Report: Influenza drug market sales to reach $2.5 billion in 2012.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA